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Abstract: During the spring of 2009, a new influenza A (H1N1) virus of swine origin emerged and spread worldwide causing a 
pandemic influenza. Here, 329 naso-pharyngeal swabs collected from patients with flu-like symptoms were analyzed by real-
time PCR for the presence of H1N1 2009 pandemic virus. Twenty-five samples collected from immunocompetent and 
immunodepressed patients contained the H1N1 pandemic virus. Phylogenetic analysis of the hemagglutinin and neuraminidase 
genes showed no obvious differences in terms of similarity and/or homology between the sequences identified in 
immunocompetent individuals and those obtained from immunocompromised patients. Pre-existing clinical conditions may 
influence the outcome of H1N1 disease. 
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  In the early spring of 2009, Mexico and the United States 
reported clusters of human pneumonia cases caused by a novel 
H1N1 influenza A virus. This virus spread subsequently across 
the globe at an unprecedented rate, prompting the WHO to 
declare a pandemic in June 2009. Phylogenetic analysis has 
inferred that the virus is likely a reassortant between a North 
American triple-reassortant swine H1N1 or H1N2 virus and a 
Eurasian lineage H1N1 swine influenza virus [1, 2]. The 
analysis showed that the H1 of this reassortant originated from 
American pigs, while NA and MP were more likely from 
European pigs. All of the 2009 isolates appear homogeneous 
and cluster together, although they are distinct from classical 
human A (H1N1) viruses [3]. Bayesian molecular-clock 
analysis of each gene of this novel H1N1 virus [4] concluded 
that the mean evolutionary rate is typical of that of swine 
influenza viruses, but that the duration of unsampled diversity 
for each gene segment had means that ranged from 9.24 to 
17.15 years, suggesting that the proposed ancestors of this virus 
may have been circulating undetected for nearly a decade. 
Inadequate surveillance and characterization of influenza A 
viruses that circulate in swine have been blamed for this 
evolutionary gap. Also a recent study showed that the domestic 
birds could act as intermediate hosts of H1N1 reassortants [5]. 
Multiple genetic groups have been recognized, including one 
recently predominant lineage [6], but any possible clinical 
importance of different lineages remains uncertain. To date, 
reassortment has not occurred with human influenza viruses. 
The level of pulmonary replication of the 2009 H1N1 virus has 
been higher than that of seasonal influenza A (H1N1) viruses in 
animals infected experimentally [7-9], but the 2009 pandemic 
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strain generally lacks mutations that are associated with 
increased pathogenicity in other influenza viruses [10]. 
  Here, a phylogenetic study was carried out on the H1N1 
2009 pandemic viruses isolated from immunocompetent and 
immunocompromised patients admitted at Tor Vergata hospital 
for flu-like symptoms. Influenza-like illness was defined as the 
presence of fever >38º C and at least another constitutional 
symptom (asthenia, headache, malaise, sweating, and chills) and 
one respiratory symptom (cough, sore throat, nasal congestion). 
  From September 2009 through March 2010, 329 naso-
pharyngeal swabs were collected from patients (127 females 
and 202 males) admitted at the Polyclinic Tor Vergata for flu-
like symptoms. Patient’s age ranged from 1 to 93 years old. The 
specimens were analysed at the Laboratory of Molecular 
Virology, Foundation Polyclinic Tor Vergata, Rome, Italy, for 
the presence of influenza viruses type A and B. 
  Viral RNA was extracted with the QIAamp RNA mini kit 
according to the manufacturer’s instruction (QIAGEN S.P.A., 
Milan, Italy). The RNA was eluted in a volume of 60 l and 
stored at 80°- C until analysis. The influenza virus was detected 
by qualitative real-time PCR using the Influenza virus A/B 
assay (Cepheid, Sunnyvalle, CA, USA) run on the SmartCycler 
platform (Cepheid, Sunnyvalle, CA, USA). Influenza A positive 
cases were re-amplified with primers targeting the hemaglutinin 
(HA) and neuraminidase (NA) genes of influenza A (H1N1) 
2009 pandemic virus. The primer sequences were as follows: F-
HA 5’- TGGGGCCATTGCCGGTTTCA-3’ (nucleotide position 
1041-1060) and R-HA 5’TGCCCCCAGGGAGACTACCA -3’ 
(nucleotide position 1647–1628); F-NA 5’-GCCCAGACAAT 
GGGGCAGTGG-3’ (nucleotide position 590-610) and R-NA 
5’-CCGTCTGGCCAAGACCAACCC-3’ (nucleotide position 
1379-1359). Reverse-transcription and amplification was 
carried out using the OneStep RT-PCR Kit according to the 
manufacturer’s instructions (QIAGEN S S.P.A., Milan, Italy). The Pandemic H1N1 Virus  The Open Virology Journal, 2011, Volume 5    23 
  The PCR products were analyzed on a 2% agarose gel 
stained with ethidium bromide and visualized under ultraviolet 
light. All the necessary precautions were taken to avoid 
contamination. 
  The HA and NA amplified fragments were sequenced using 
the Genome Lab DTCS Quick Start Kit (Beckman Coulter, 
Fullerton, CA, USA) and run on a Beckman Coulter CEQ 8000 
Genetic Analysis System (Fullerton, CA, USA) after column 
purification. The obtained sequences were submitted to the 
Genbank and matched against all deposited sequences 
(http://www.ncbi.nlm.nih.gov/BLAST). 
  An alignment with a set of reference sequences was 
obtained using CLUSTAL X [11] and manually edited with the 
Bioedit software [12]. The evolutionary model was chosen as 
the best-fitting nucleotide substitution model, according to the 
Hierarchical Likelihood Ratio Test (HLRT) implemented in the 
Model Test V3.0 software [13]. The statistical robustness and 
reliability of the branching order within each phylogenetic tree 
were confirmed by bootstrap analysis using 1000 replicates for 
the NJ tree and with the Zero Branch Length Test for the 
Maximum Likelihood (ML) tree. All calculations were 
performed with PAUP*4.0 software [14]. Trees were rooted as 
mid point root. The accession numbers of the sequences utilized 
for phylogenetic analysis including those referred to influenza A 
virus (H1N1) strains identified in our laboratory and labelled 
A/ROME/PTV1 to 25 are reported in Appendix Table 1. 
  Twenty-five H1N1 2009 pandemic viruses were identified. 
Of these, six were from immunodepressed patients (five with 
hematological malignancies and one HIV-1 infected) and nine-
teen from immunocompetent individuals (Table 1). A Maxi-
mum Likelihood phylogenetic tree was generated for the HA 
and NA genes (Figs. 1, 2). In the HA tree, a main clade was 
generated where the strains collected from Italian immunodep-
ressed patients and Indian fatal cases [15] (in bold) intermixed 
with those obtained from immunocompetent Italian patients or 
Indian recovered cases (regular font). This is clearly shown by 
the strains A/Pune/NIV10278/2009 and A/Pune/NIV9355/2009 
obtained from two fatal cases which cluster with the strain 
A/Blore/NIV236/2009 isolated from a recovered patient; and 
outside the main clade, by the strain A/Rome/PTV24/2010 
isolated from an immunocompromised patient which clusters 
with the strain A/Rome/PTV12/2010 and A/Rome/PTV23/2010 
 
Table 1.  Clinical and Demographic Characteristics of the 25 Italian Patients Infected with the Pandemic H1N1 Influenza Virus 
 
Patient  Isolate  Age Years/Sex  Isolation Date  Immuno Depression   H1N1 Influenza Outcome 
1 A/Rome/PTV1/2010  28/F  01/11/2009  No  Recovered 
2  A/Rome/PTV2/2010  49/F 01/11/2009  Yes  Recovered 
3 A/Rome/PTV3/2010  8/M  02/11/2009  No  Recovered 
4 A/Rome/PTV4/2010  41/M  04/11/2009  No  Recovered 
5 A/Rome/PTV5/2010  19/M  04/11/2009  No  Recovered 
6 A/Rome/PTV6/2010  57/M  04/11/2009  No  Recovered 
7 A/Rome/PTV7/2010  50/M  06/11/2009  No  Recovered 
8  A/Rome/PTV8/2010  51/M 07/11/2009  Yes  Recovered 
9  A/Rome/PTV9/2010  62/M 12/11/2009  Yes  Recovered 
10 A/Rome/PTV10/2010  45/F  12/11/2009  No  Recovered 
11 A/Rome/PTV11/2010  40/F  13/11/2009  No  Recovered 
12 A/Rome/PTV12/2010  55/F  13/11/2009  No  Recovered 
13 A/Rome/PTV13/2010  53/M  13/11/2009  No  Recovered 
14 A/Rome/PTV14/2010  17/M  15/11/2009  No  Recovered 
15 A/Rome/PTV15/2010  41/M  18/11/2009  No  Recovered 
16 A/Rome/PTV16/2010  75/F  18/11/2009  No  Recovered 
17 A/Rome/PTV17/2010  27/F  20/11/2009  No  Recovered 
18  A/Rome/PTV18/2010  12/M 23/11/2009  Yes  Recovered 
19 A/Rome/PTV19/2010  23/M  23/11/2009  No  Recovered 
20  A/Rome/PTV20/2010  27/F 24/11/2009  Yes  Recovered 
21 A/Rome/PTV21/2010  37/M  24/11/2009  No  Recovered 
22 A/Rome/PTV22/2010  19/M  24/11/2009  No  Recovered 
23 A/Rome/PTV23/2010  51/M  25/11/2009  No  Recovered 
24  A/Rome/PTV24/2010  52/F 25/11/2009  Yes  Recovered 
25 A/Rome/PTV25/2010  30.6/F  31/12/2009  No  Recovered 24    The Open Virology Journal, 2011, Volume 5  Ciccozzi et al. 
 
 
Fig. (1). Maximun likelihood phylogenetic analysis of H1N1 HA sequences. The data set included sequences isolated from patients admitted at Tor 
Vergata hospital. The tree was rooted by using the midpoint rooting method. Branch lengths were estimated with the best fitting nucleotide 
substitution model (HKY+I+G) according to a hierarchical likelihood ratio test, and were drawn to scale with the bar at the bottom indicating 0.0090 
nucleotide substitutions per site. One asterisk (*) along a branch represents significant statistical support for the clade subtending that branch 
(p<0.001 in the zero-branch-length test and bootstrap support >75%). The strains isolated from severe cases are in bold. 
 
Fig. (2). Maximun likelihood phylogenetic analysis of H1N1 NA sequences. The data set included sequences isolated from patients admitted at Tor 
Vergata hospital. The tree was rooted by using the midpoint rooting method. Branch lengths were estimated with the best fitting nucleotide 
substitution model (HKY+I+G) according to a hierarchical likelihood ratio test, and were drawn to scale with the bar at the bottom indicating 0.04 
nucleotide substitutions per site. One asterisk (*) along a branch represents significant statistical support for the clade subtending that branch 
(p<0.001 in the zero-branch-length test and bootstrap support .>75%). The strains isolated from severe cases are in bold. The Pandemic H1N1 Virus  The Open Virology Journal, 2011, Volume 5    25 
obtained from immunocompetent individuals. Both clusters are 
statistically supported. A similar picture was observed with the 
NA tree (Fig. 2). Even in this case the viral strains from 
immunocompromised or death patients intermixed with those 
isolated from immucompetent patients with the exception of 
two small clusters (A/Pune/NIV10604/2009, A/Pune/NIV6196/ 
2009 and A/Rome/PTV8/2010, A/Rome/PTV9/2010) which 
were collected from two fatal cases and immunocompromised 
patients, respectively. 
  The results of this study indicate no obvious differences in 
viral sequences between the H1N1 pandemic viruses isolated   
from immunocompetent individuals and those identified in 
 
 
recovered immunocompromised patients and/or fatal cases. We 
can exclude that the lack of sequence variations observed in 
Italian immunocompetent and immunocompromised patients 
was due to contamination of virus sequences since the samples 
and sequencing were handled appropriately using separate 
rooms and including controls in each run as also shown by the 
phylogenetic trees. 
  Indeed, mutations that have been linked to fatal cases have 
also been detected in recovered cases [15, 16]; therefore their 
role in viral pathogenesis remains unclear. Preexisting specific 
severe clinical conditions may play an important role in 
determining the outcome of H1N1disease [17]. 
 
 
APPENDIX 
Table A1.  H1N1 2009 Pandemic Virus Sequences Used in this Study 
 
Virus Strain  Accession no HA  Accession no NA  Age/Sex  Influenza Outcome   Country  Collection Date 
A/California/04/2009 GQ280797  FJ969517  10/M  recovered  California  01/04/2009 
A/California/05/2009 FJ966952  FJ966956  9/F  recovered  California  30/03/2009 
A/Regensburg/Germany/01/2009 FJ974021  FJ984953  37/M  recovered Germany  27/04/2009 
A/Istanbul/30/2009 GQ200598  GQ200599  26/M  recovered  Turkey  14/05/2009 
A/Pune/NIV10278/2009 GU292344  N  6/M  Death  India  Sep-2009 
A/Pune/NIV10604/2009 GU292345  HM241726  3/F  Death  India  Sep-2009 
A/Blore/NIV236/2009 GU292346  GU292381  2.5/  M  Recovered  India  26  /06/2009 
A/Blore/NIV310/2009 GU292347  GU292382  9/F  Recovered  India  01/07/2009 
A/Delhi/NIV3610/2009 GU292348  N*  12/M  Recovered  India  13  /08/2009 
A/Delhi/NIV3704/2009 GU292349  N  13/M  Recovered  India  08/09/2009 
A/Hyd/NIV51/2009 GU292350  GU292383  23/M  Recovered  India  13/05/2009 
A/Mum/NIV5442/2009 GU292351  N  2  months/  F  Death  India  16/08/2009 
A/Pune/NIV6196/2009 GU292352  GU292384  17/M  Death India  16  /08/2009 
A/Pune/NIV6447/2009 GU292353  GU292385  22/F  Death India  17  /08/2009 
A/Pune/NIV8489/2009 GU292354  GU292386  42/F  Death India  22  /08/2009 
A/Pune/NIV9355/2009  GU292355  N  20/M  Death  India  29 /08/ 2009 
A/Mum/NIV9945/2009 GU292356  N  N/M  Death  India  3  /09/2009 
A/Rome/PTV1/2009  HM625622 HM625647 28/F  recovered  Italy  01/11/2009 
A/Rome/PTV2/2009    HM625623 HM625648 49/F  recovered  Italy  01/11/2009 
A/Rome/PTV3/2009   HM625624  HM625649  8/M  recovered  Italy  02/11/2009 
A/Rome/PTV4/2009   HM625625  HM625650  41/M  recovered  Italy  04/11/2009 
A/Rome/PTV5/2009   HM625626  HM625651  19/M  recovered  Italy  04/11/2009 
A/Rome/PTV6/2009   HM625627  HM625652  57/M  recovered  Italy  04/11/2009 
A/Rome/PTV7/2009   HM625628  HM625653  50/M  recovered  Italy  06/11/2009 
A/Rome/PTV8/2009   HM625629  HM625654  51/M  recovered  Italy  07/11/2009 
A/Rome/PTV9/2009   HM625630  HM625656  62/M  recovered  Italy  12/11/2009 
A/Rome/PTV10/2009    HM625631 HM625655 45/F  recovered  Italy  12/11/2009 
A/Rome/PTV11/2009    HM625632 HM625657 40/F  recovered  Italy  13/11/2009 
A/Rome/PTV12/2009    HM625633 HM625658 55/F  recovered  Italy  13/11/2009 
A/Rome/PTV13/2009   HM625634  HM625659  53/M  recovered  Italy  13/11/2009 
A/Rome/PTV14/2009   HM625635  HM625660  17/M  recovered  Italy  15/11/2009 
A/Rome/PTV15/2009   HM625636  HM625661  41/M  recovered  Italy  18/11/2009 
A/Rome/PTV16/2009    HM625637 HM625662 75/F  recovered  Italy  18/11/2009 
A/Rome/PTV17/2009    HM625638 HM625663 27/F  recovered  Italy  20/11/2009 
A/Rome/PTV18/2009   HM625639  HM625664  12/M  recovered  Italy  23/11/2009 
A/Rome/PTV19/2009   HM625640  HM625665  23/M  recovered  Italy  23/11/2009 
A/Rome/PTV20/2009    HM625641 HM625666 27/F  recovered  Italy  24/11/2009 
A/Rome/PTV21/2009   HM625642  HM625667  37/M  recovered  Italy  24/11/2009 
A/Rome/PTV22/2009   HM625643  HM625668  19/M  recovered  Italy  24/11/2009 
A/Rome/PTV23/2009   HM625644  HM625669  51/M  recovered  Italy  25/11/2009 
A/Rome/PTV24/2009    HM625645 HM625670 52/F  recovered  Italy  25/11/2009 
A/Rome/PTV25/2009    HM625646  HM625671  30.6/F recovered Italy  19/01/2010 
*N = data not available. 26    The Open Virology Journal, 2011, Volume 5  Ciccozzi et al. 
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